Ligand-modified nanocarriers for oral drug delivery: Challenges, rational design, and applications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ligand-modified nanocarriers for oral drug delivery: Challenges, rational design, and applications

Published:2022-12 Issue: Volume:352 Page:813-832
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Zhang Yaqi,Wang Yaying,Li Xiang,Nie Di,Liu Chang,Gan Yong

Funder

Chinese Academy of Sciences

Science and Technology Commission of Shanghai Municipality

National Science Fund for Distinguished Young Scholars

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference168 articles.

1. Oral administration of protein nanoparticles: an emerging route to disease treatment;Sadeghi;Pharmacol. Res.,2020

2. The application of biomacromolecules to improve oral absorption by enhanced intestinal permeability: a mini-review;Sun;Chin. Chem. Lett.,2020

3. Oral delivery of biologics for precision medicine;Duran-Lobato;Adv. Mater.,2020

4. Overcoming the intestinal barrier: a look into targeting approaches for improved oral drug delivery systems;Xu;J. Control. Release,2020

5. A quantitative view on multivalent nanomedicine targeting;Woythe;Adv. Drug Deliv. Rev.,2021

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solubilization techniques used for poorly water-soluble drugs;Acta Pharmaceutica Sinica B;2024-09

2. Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation;Acta Pharmaceutica Sinica B;2024-09

3. Milk Exosome–Liposome Hybrid Vesicles with Self-Adapting Surface Properties Overcome the Sequential Absorption Barriers for Oral Delivery of Peptides;ACS Nano;2024-08-05

4. Endoplasmic reticulum-targeted delivery of celastrol and PD-L1 siRNA for reinforcing immunogenic cell death and potentiating cancer immunotherapy;Acta Pharmaceutica Sinica B;2024-08

5. Oral Delivery of Photoresponsive Milk-Derived Exosomes for the Local Therapy of Glioblastoma;ACS Materials Letters;2024-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3